PEPTIDE THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Product Type
• Market Snapshot, By Application
• Market Snapshot, By Route of Administration
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Attractiveness Analysis
• Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER’s Analysis
• Pricing Analysis (2022)
•  Economic Impact
• Impact on Supply and Demand

4. Global Peptide Therapeutics Market, By Product Type, 2021–2033, (US$ Million)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Branded Peptide
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Generic Peptide
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)

5. Global Peptide Therapeutics Market, By Application, 2021–2033, (US$ Million)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Cancer
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Cardiovascular Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Metabolic Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Respiratory Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Infectious Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)

6. Global Peptide Therapeutics Market, By Route of Administration, 2021–2033, (US$ Million)

• Oral Administration
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Parenteral Administration
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)

7. Global Peptide Therapeutics Market, By Region, 2021–2033, (US$ Million)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Regions, 2022–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021– 2033, (US$ Million)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021–2033, (US$ Million)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Teva Pharmaceutical Industries Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Novo Nordisk A/S
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• OPKO Health, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Lilly
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Hanmi Pharm.Co.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Circle Pharma
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Novartis AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• PeptiDream Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Amgen Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• AstraZeneca
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bachem Holding AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• CordenPharma International
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Ipsen Pharma
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Merck KGaA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• PolyPeptide Group
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies

9. Section

• Research Methodology
• About Us